From Casetext: Smarter Legal Research

Pharma Res. GmbH v. Oncogenerix Co.

United States District Court, S.D. New York
Jun 7, 2022
21 CIVIL 7240 (AKH) (S.D.N.Y. Jun. 7, 2022)

Opinion

21 CIVIL 7240 (AKH)

06-07-2022

PHARMA RESOURCES GMBH, Petitioner, v. ONCOGENERIX COMPANY LIMITED, Rpennndpnt


JUDGMENT

It is hereby ORDERED, ADJUDGED AND DECREED: That for the reasons stated in the Court's Order dated June 7, 2022, it therefore follows that this Court has original jurisdiction over this dispute under Section 203, satisfying the independent jurisdictional basis required under Section 4. Because Respondent offers no other reasons to deny-and indeed, admits all of the factual allegations in support of granting-the Petition, the Court must enter an order "directing the parties to proceed to arbitration in accordance with the terms of the agreement." 9 U.S.C. § 4. Petitioner specifically requests an order compelling Respondent to appear and participate in proceedings before the AAA. Pet. Paragraph 30. The Agreement itself does not specify that the parties must arbitrate before the AAA, so such an order ordinarily would not be "in accordance with the terms of the agreement." However, because Respondent does not dispute (i.e., admits) that Petitioner is "entitled to an[] Order compelling and directing [Respondent] to appear and participate in an arbitration proceeding before the AAA in New York, New York[, ]" Pet. Paragraph 30; Decl. Paragraph 3, the Court has granted Petitioner's motion to compel arbitration and orders Respondent to appear and participate in a proceeding before the AAA; accordingly, the case is closed.


Summaries of

Pharma Res. GmbH v. Oncogenerix Co.

United States District Court, S.D. New York
Jun 7, 2022
21 CIVIL 7240 (AKH) (S.D.N.Y. Jun. 7, 2022)
Case details for

Pharma Res. GmbH v. Oncogenerix Co.

Case Details

Full title:PHARMA RESOURCES GMBH, Petitioner, v. ONCOGENERIX COMPANY LIMITED…

Court:United States District Court, S.D. New York

Date published: Jun 7, 2022

Citations

21 CIVIL 7240 (AKH) (S.D.N.Y. Jun. 7, 2022)